VEGFA and ovarian carcinoma: The standard of care treatment for ovarian cancer is cytoreductive (debulking) surgery, platinum-based and taxane combination chemotherapy, and maintenance therapy using poly (ADP-ribose) polymerase inhibitors (PARPi) and/or bevacizumab (an inhibitor of vascular endothelial growth factor (VEGF)) [98,99].